Donor Advised Charitable Giving’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-360
Closed -$213K – 48
2022
Q1
$213K Hold
360
– – 0.02% 49
2021
Q4
$240K Hold
360
– – 0.02% 43
2021
Q3
$206K Sell
360
-660
-65% -$362K 0.04% 50
2021
Q2
$515K Hold
1,020
– – 0.06% 86
2021
Q1
$466K Hold
1,020
– – 0.05% 88
2020
Q4
$475K Sell
1,020
-180
-15% -$84.4K 0.06% 84
2020
Q3
$530K Hold
1,200
– – 0.15% 23
2020
Q2
$435K Hold
1,200
– – 0.17% 24
2020
Q1
$340K Hold
1,200
– – 0.17% 26
2019
Q4
$390K Hold
1,200
– – 0.21% 29
2019
Q3
$350K Hold
1,200
– – 0.27% 33
2019
Q2
$352K Buy
+1,200
New +$331K 0.28% 32

Other funds holding TMO

Donor Advised Charitable Giving's TMO Position: Q2 2022 in Review

Donor Advised Charitable Giving sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 360 shares — an estimated $213K sold.

Donor Advised Charitable Giving first reported a position in TMO in Q2 2019 and held it in 12 quarters. The position peaked at $530K in Q3 2020. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Donor Advised Charitable Giving reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Donor Advised Charitable Giving sold 360 Thermo Fisher Scientific shares in Q2 2022, an estimated $213K.
  • Donor Advised Charitable Giving first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 12 quarters.
  • Donor Advised Charitable Giving's Thermo Fisher Scientific position peaked at $530K in Q3 2020.
  • 2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Donor Advised Charitable Giving's 13F filing for Q2 2022, filed 29 Jul 2022.